Orexo AB
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | OXD01 in Combination With Sublingual Buprenorphine/Naloxone for Treatment of Opioid Use Disorder Opioid-use Disorder | N/A | 2021-06-30 |
| Completed | Efficacy of BNX Sublingual Tablets Versus BNX Sublingual Film for Treatment of Opioid-Dependent Adults Opioid Dependence, on Agonist Therapy | Phase 3 | 2013-08-01 |
| Completed | Multi-Center, Open-Label, 24-Week Study of OX219 Safety and Efficacy for Maintenance Treatment of Opioid Depen Opioid Dependence, on Agonist Therapy | Phase 4 | 2013-07-01 |
| Completed | Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Depende Opioid-Related Disorders, Opiate Dependence | Phase 3 | 2013-06-01 |
| Terminated | Conversion From Fast Acting Oral Opioids to Abstral® Pain | Phase 4 | 2011-02-21 |